Back to today’s briefing

Story perspectives

Neuralink Secures $500M for Brain Implant Trials

4/24/2025

32 4

Summary

Story summary

Neuralink, founded by Elon Musk, seeks to raise $500 million with an $8.5 billion valuation.
The company is developing brain implants to help individuals with spinal cord injuries engage in activities like gaming and browsing.
Following an initial FDA rejection, Neuralink has received approval for ongoing clinical trials.
Musk aims for the technology to address a range of mental health conditions in the future.

1 of 1

Story summary

Neuralink, founded by Elon Musk, seeks to raise $500 million with an $8.5 billion valuation.
The company is developing brain implants to help individuals with spinal cord injuries engage in activities like gaming and browsing.
Following an initial FDA rejection, Neuralink has received approval for ongoing clinical trials.
Musk aims for the technology to address a range of mental health conditions in the future.